Indeed Snapshot

Track Vanda Pharmaceuticals reviews on Indeed to uncover insights on employee sentiment

Rows

Open dataset
Ticker Symbol Entity Name As Of Date Profile Url Name Website Industry Description Revenue Headquarters location CEO Rating: CEO (%) Rating: CEO Responses Count Rating: Overall Happiness: Compensation score Happiness: Support score Happiness: Purpose score Happiness: Flexibility score Happiness: Energy score Happiness: Work Happiness score Happiness: Trust score Happiness: Learning score Happiness: Belonging score Happiness: Inclusion score Happiness: Overall score Happiness: Appreciation score Happiness: Achievement score Happiness: Responses Count Review Count Ratings Responses Count Rating: Culture & Values Rating: Compensation & Benefits Rating: Job Security & Advancement Rating: Senior Management Rating: Worklife Balance Interview: Duration Responses count Interview Duration Interview: Difficulty Responses count Interview Difficulty Interview: Experience Responses count Interview Experience Work Culture: Stressful (0) to Relaxed (1) Ratio Work Culture: Slow Paced (0) to Fast Paced (1) Ratio Work Culture: Competitive (0) to Collaborative (1) Ratio Date Added Date Updated Company Name Sector Industry
nasdaq:vnda https://www.indeed.com/cmp/vanda-pharmaceuticals Aug 29th, 2022 12:00AM Open Vanda Pharmaceuticals Pharmaceutical & Biotechnology Vanda is developing important new medicines to improve the lives of patients. We use new technologies, including genetics and genomics, to inform our drug discovery, our clinical trials, and our commercial positioning of our compounds. We are working to advance the use of novel approaches to deliver these new medicines to patients. Our CEO, Mihael Polymeropoulos, MD, founded Vanda in 2003 in partnership with Care Capital LLC, a prominent biopharmaceuticals-focused investment firm, and Bio*One Capital, an investment arm of the Singapore government with a focus on new biomedical enterprises. RRv1_100M_500M Washington, DC Mihael H. Polymeropoulos 3.00 15.00 15.00 2.60 4.00 2.50 2.60 3.40 5.00 MEDIUM 5.00 FAVORABLE Aug 29th, 2022 12:45PM Aug 29th, 2022 12:45PM Vanda Pharmaceuticals Health Care Pharmaceuticals & Biotechnology
nasdaq:vnda https://www.indeed.com/cmp/vanda-pharmaceuticals Aug 28th, 2022 12:00AM Open Vanda Pharmaceuticals Pharmaceutical & Biotechnology Vanda is developing important new medicines to improve the lives of patients. We use new technologies, including genetics and genomics, to inform our drug discovery, our clinical trials, and our commercial positioning of our compounds. We are working to advance the use of novel approaches to deliver these new medicines to patients. Our CEO, Mihael Polymeropoulos, MD, founded Vanda in 2003 in partnership with Care Capital LLC, a prominent biopharmaceuticals-focused investment firm, and Bio*One Capital, an investment arm of the Singapore government with a focus on new biomedical enterprises. RRv1_100M_500M Washington, DC Mihael H. Polymeropoulos 3.00 15.00 15.00 2.60 4.00 2.50 2.60 3.40 5.00 MEDIUM 5.00 FAVORABLE Aug 28th, 2022 05:46AM Aug 28th, 2022 05:46AM Vanda Pharmaceuticals Health Care Pharmaceuticals & Biotechnology
nasdaq:vnda https://www.indeed.com/cmp/vanda-pharmaceuticals Aug 27th, 2022 12:00AM Open Vanda Pharmaceuticals Pharmaceutical & Biotechnology Vanda is developing important new medicines to improve the lives of patients. We use new technologies, including genetics and genomics, to inform our drug discovery, our clinical trials, and our commercial positioning of our compounds. We are working to advance the use of novel approaches to deliver these new medicines to patients. Our CEO, Mihael Polymeropoulos, MD, founded Vanda in 2003 in partnership with Care Capital LLC, a prominent biopharmaceuticals-focused investment firm, and Bio*One Capital, an investment arm of the Singapore government with a focus on new biomedical enterprises. RRv1_100M_500M Washington, DC Mihael H. Polymeropoulos 3.00 15.00 15.00 2.60 4.00 2.50 2.60 3.40 5.00 MEDIUM 5.00 FAVORABLE Aug 27th, 2022 05:04AM Aug 27th, 2022 05:04AM Vanda Pharmaceuticals Health Care Pharmaceuticals & Biotechnology
nasdaq:vnda https://www.indeed.com/cmp/vanda-pharmaceuticals Aug 25th, 2022 12:00AM Open Vanda Pharmaceuticals Pharmaceutical & Biotechnology Vanda is developing important new medicines to improve the lives of patients. We use new technologies, including genetics and genomics, to inform our drug discovery, our clinical trials, and our commercial positioning of our compounds. We are working to advance the use of novel approaches to deliver these new medicines to patients. Our CEO, Mihael Polymeropoulos, MD, founded Vanda in 2003 in partnership with Care Capital LLC, a prominent biopharmaceuticals-focused investment firm, and Bio*One Capital, an investment arm of the Singapore government with a focus on new biomedical enterprises. RRv1_100M_500M Washington, DC Mihael H. Polymeropoulos 3.00 15.00 15.00 2.60 4.00 2.50 2.60 3.40 5.00 MEDIUM 5.00 FAVORABLE Aug 25th, 2022 09:43AM Aug 25th, 2022 09:43AM Vanda Pharmaceuticals Health Care Pharmaceuticals & Biotechnology
nasdaq:vnda https://www.indeed.com/cmp/vanda-pharmaceuticals Aug 23rd, 2022 12:00AM Open Vanda Pharmaceuticals Pharmaceutical Vanda is developing important new medicines to improve the lives of patients. We use new technologies, including genetics and genomics, to inform our drug discovery, our clinical trials, and our commercial positioning of our compounds. We are working to advance the use of novel approaches to deliver these new medicines to patients. Our CEO, Mihael Polymeropoulos, MD, founded Vanda in 2003 in partnership with Care Capital LLC, a prominent biopharmaceuticals-focused investment firm, and Bio*One Capital, an investment arm of the Singapore government with a focus on new biomedical enterprises. RRv1_100M_500M Washington, DC 3.00 15.00 15.00 2.60 4.00 2.50 2.60 3.40 5.00 MEDIUM 5.00 FAVORABLE Aug 23rd, 2022 11:36AM Aug 23rd, 2022 11:36AM Vanda Pharmaceuticals Health Care Pharmaceuticals & Biotechnology
nasdaq:vnda https://www.indeed.com/cmp/vanda-pharmaceuticals Aug 21st, 2022 12:00AM Open Vanda Pharmaceuticals Pharmaceutical Vanda is developing important new medicines to improve the lives of patients. We use new technologies, including genetics and genomics, to inform our drug discovery, our clinical trials, and our commercial positioning of our compounds. We are working to advance the use of novel approaches to deliver these new medicines to patients. Our CEO, Mihael Polymeropoulos, MD, founded Vanda in 2003 in partnership with Care Capital LLC, a prominent biopharmaceuticals-focused investment firm, and Bio*One Capital, an investment arm of the Singapore government with a focus on new biomedical enterprises. RRv1_100M_500M Washington, DC 3.00 15.00 15.00 2.60 4.00 2.50 2.60 3.40 5.00 MEDIUM 5.00 FAVORABLE Aug 21st, 2022 01:21PM Aug 21st, 2022 01:21PM Vanda Pharmaceuticals Health Care Pharmaceuticals & Biotechnology
nasdaq:vnda https://www.indeed.com/cmp/vanda-pharmaceuticals Aug 20th, 2022 12:00AM Open Vanda Pharmaceuticals Pharmaceutical Vanda is developing important new medicines to improve the lives of patients. We use new technologies, including genetics and genomics, to inform our drug discovery, our clinical trials, and our commercial positioning of our compounds. We are working to advance the use of novel approaches to deliver these new medicines to patients. Our CEO, Mihael Polymeropoulos, MD, founded Vanda in 2003 in partnership with Care Capital LLC, a prominent biopharmaceuticals-focused investment firm, and Bio*One Capital, an investment arm of the Singapore government with a focus on new biomedical enterprises. RRv1_100M_500M Washington, DC 3.00 15.00 15.00 2.60 4.00 2.50 2.60 3.40 5.00 MEDIUM 5.00 FAVORABLE Aug 20th, 2022 02:59PM Aug 20th, 2022 02:59PM Vanda Pharmaceuticals Health Care Pharmaceuticals & Biotechnology
nasdaq:vnda https://www.indeed.com/cmp/vanda-pharmaceuticals Aug 19th, 2022 12:00AM Open Vanda Pharmaceuticals Pharmaceutical Vanda is developing important new medicines to improve the lives of patients. We use new technologies, including genetics and genomics, to inform our drug discovery, our clinical trials, and our commercial positioning of our compounds. We are working to advance the use of novel approaches to deliver these new medicines to patients. Our CEO, Mihael Polymeropoulos, MD, founded Vanda in 2003 in partnership with Care Capital LLC, a prominent biopharmaceuticals-focused investment firm, and Bio*One Capital, an investment arm of the Singapore government with a focus on new biomedical enterprises. RRv1_100M_500M Washington, DC 3.00 15.00 15.00 2.60 4.00 2.50 2.60 3.40 5.00 MEDIUM 5.00 FAVORABLE Aug 19th, 2022 01:20PM Aug 19th, 2022 01:20PM Vanda Pharmaceuticals Health Care Pharmaceuticals & Biotechnology
nasdaq:vnda https://www.indeed.com/cmp/vanda-pharmaceuticals Aug 18th, 2022 12:00AM Open Vanda Pharmaceuticals Pharmaceutical Vanda is developing important new medicines to improve the lives of patients. We use new technologies, including genetics and genomics, to inform our drug discovery, our clinical trials, and our commercial positioning of our compounds. We are working to advance the use of novel approaches to deliver these new medicines to patients. Our CEO, Mihael Polymeropoulos, MD, founded Vanda in 2003 in partnership with Care Capital LLC, a prominent biopharmaceuticals-focused investment firm, and Bio*One Capital, an investment arm of the Singapore government with a focus on new biomedical enterprises. RRv1_100M_500M Washington, DC 3.00 15.00 15.00 2.60 4.00 2.50 2.60 3.40 5.00 MEDIUM 5.00 FAVORABLE Aug 18th, 2022 05:04AM Aug 18th, 2022 05:04AM Vanda Pharmaceuticals Health Care Pharmaceuticals & Biotechnology
nasdaq:vnda https://www.indeed.com/cmp/vanda-pharmaceuticals Aug 17th, 2022 12:00AM Open Vanda Pharmaceuticals Pharmaceutical Vanda is developing important new medicines to improve the lives of patients. We use new technologies, including genetics and genomics, to inform our drug discovery, our clinical trials, and our commercial positioning of our compounds. We are working to advance the use of novel approaches to deliver these new medicines to patients. Our CEO, Mihael Polymeropoulos, MD, founded Vanda in 2003 in partnership with Care Capital LLC, a prominent biopharmaceuticals-focused investment firm, and Bio*One Capital, an investment arm of the Singapore government with a focus on new biomedical enterprises. RRv1_100M_500M Washington, DC 3.00 15.00 15.00 2.60 4.00 2.50 2.60 3.40 5.00 MEDIUM 5.00 FAVORABLE Aug 17th, 2022 10:43AM Aug 17th, 2022 10:43AM Vanda Pharmaceuticals Health Care Pharmaceuticals & Biotechnology

Request a demo to view additional historical data, and much more.

Request Demo

Make fast
queries

No longer rely on engineers to access data; build and share queries with intuitive tools, and derive insights in real time.

Bookmark queries with your team

Save and share custom queries using a private bookmarking feature, accessible to your whole team.

Be first to know with alerts

Scan data points across millions of companies and receive emails when relevant metrics cross critical thresholds.

Visualize data for quick insights

Create custom keyword-based word clouds, charts, and advanced visualizations to quickly analyze the data.

Map competitor locations

Analyze competitor presence and growth over time by overlaying store locations with the Nearby Competitor feature.

Add widgets to your dashboards

Access existing maps, charts, word clouds, and other visualizations to understand your data quickly. Or build custom widgets to view data just the way you want it.